277 related articles for article (PubMed ID: 14583103)
1. Phytoestrogens: potential benefits and implications for breast cancer survivors.
Duffy C; Cyr M
J Womens Health (Larchmt); 2003 Sep; 12(7):617-31. PubMed ID: 14583103
[TBL] [Abstract][Full Text] [Related]
2. Implications of phytoestrogen intake for breast cancer.
Duffy C; Perez K; Partridge A
CA Cancer J Clin; 2007; 57(5):260-77. PubMed ID: 17855484
[TBL] [Abstract][Full Text] [Related]
3. Do phytoestrogens reduce the risk of breast cancer and breast cancer recurrence? What clinicians need to know.
Velentzis LS; Woodside JV; Cantwell MM; Leathem AJ; Keshtgar MR
Eur J Cancer; 2008 Sep; 44(13):1799-806. PubMed ID: 18614351
[TBL] [Abstract][Full Text] [Related]
4. Risks and benefits of soy isoflavones for breast cancer survivors.
Hu SA
Oncol Nurs Forum; 2004; 31(2):249-63. PubMed ID: 15017441
[TBL] [Abstract][Full Text] [Related]
5. [Phytoestrogens].
Zittermann A
Zentralbl Gynakol; 2003 Jun; 125(6):195-201. PubMed ID: 14556117
[TBL] [Abstract][Full Text] [Related]
6. Addressing the soy and breast cancer relationship: review, commentary, and workshop proceedings.
Messina M; McCaskill-Stevens W; Lampe JW
J Natl Cancer Inst; 2006 Sep; 98(18):1275-84. PubMed ID: 16985246
[TBL] [Abstract][Full Text] [Related]
7. Estrogen dependent growth inhibitory effects of tamoxifen but not genistein in solid tumors derived from estrogen receptor positive (ER+) primary breast carcinoma MCF7: single agent and novel combined treatment approaches.
Nobert GS; Kraak MM; Crawford S
Bull Cancer; 2006 Jul; 93(7):E59-66. PubMed ID: 16873071
[TBL] [Abstract][Full Text] [Related]
8. Effect of dietary intake of phytoestrogens on estrogen receptor status in premenopausal women with breast cancer.
Touillaud MS; Pillow PC; Jakovljevic J; Bondy ML; Singletary SE; Li D; Chang S
Nutr Cancer; 2005; 51(2):162-9. PubMed ID: 15860438
[TBL] [Abstract][Full Text] [Related]
9. Phytoestrogens and breast cancer: a complex story.
Helferich WG; Andrade JE; Hoagland MS
Inflammopharmacology; 2008 Oct; 16(5):219-26. PubMed ID: 18815740
[TBL] [Abstract][Full Text] [Related]
10. [Dietary phytoestrogen and its potential benefits in adult human health].
Garrido A; de la Maza MP; Valladares L
Rev Med Chil; 2003 Nov; 131(11):1321-8. PubMed ID: 14743696
[TBL] [Abstract][Full Text] [Related]
11. Dissemination of adjuvant multiagent chemotherapy and tamoxifen for breast cancer in the United States using estrogen receptor information: 1975-1999.
Mariotto AB; Feuer EJ; Harlan LC; Abrams J
J Natl Cancer Inst Monogr; 2006; (36):7-15. PubMed ID: 17032888
[TBL] [Abstract][Full Text] [Related]
12. Interactions of isoflavones and other plant derived estrogens with estrogen receptors for prevention and treatment of breast cancer-considerations concerning related efficacy and safety.
Leclercq G; Jacquot Y
J Steroid Biochem Mol Biol; 2014 Jan; 139():237-44. PubMed ID: 23274118
[TBL] [Abstract][Full Text] [Related]
13. Soy, disease prevention, and prostate cancer.
Moyad MA
Semin Urol Oncol; 1999 May; 17(2):97-102. PubMed ID: 10332923
[TBL] [Abstract][Full Text] [Related]
14. Soy isoflavone phyto-pharmaceuticals in interleukin-6 affections. Multi-purpose nutraceuticals at the crossroad of hormone replacement, anti-cancer and anti-inflammatory therapy.
Dijsselbloem N; Vanden Berghe W; De Naeyer A; Haegeman G
Biochem Pharmacol; 2004 Sep; 68(6):1171-85. PubMed ID: 15313415
[TBL] [Abstract][Full Text] [Related]
15. Risk of early recurrence among postmenopausal women with estrogen receptor-positive early breast cancer treated with adjuvant tamoxifen.
Kennecke H; McArthur H; Olivotto IA; Speers C; Bajdik C; Chia SK; Ellard S; Norris B; Hayes M; Barnett J; Gelmon KA
Cancer; 2008 Apr; 112(7):1437-44. PubMed ID: 18286526
[TBL] [Abstract][Full Text] [Related]
16. Hormonal breast cancer agents: implications for the primary care provider.
Lyon DE; Roux G; Voll S
J Am Acad Nurse Pract; 2006 Nov; 18(11):518-23. PubMed ID: 17064329
[TBL] [Abstract][Full Text] [Related]
17. Endogenous sex hormones, breast cancer risk, and tamoxifen response: an ancillary study in the NSABP Breast Cancer Prevention Trial (P-1).
Beattie MS; Costantino JP; Cummings SR; Wickerham DL; Vogel VG; Dowsett M; Folkerd EJ; Willett WC; Wolmark N; Hankinson SE
J Natl Cancer Inst; 2006 Jan; 98(2):110-5. PubMed ID: 16418513
[TBL] [Abstract][Full Text] [Related]
18. Phytoestrogens in health and disease.
Davis SR; Dalais FS; Simpson ER; Murkies AL
Recent Prog Horm Res; 1999; 54():185-210; discussion 210-1. PubMed ID: 10548876
[TBL] [Abstract][Full Text] [Related]
19. [Genistein induced apoptosis in MCF-7 and T47D cells].
Yu Z; Zhang L; Wu D
Wei Sheng Yan Jiu; 2003 Mar; 32(2):125-7. PubMed ID: 12793002
[TBL] [Abstract][Full Text] [Related]
20. Benefit and projected cost-effectiveness of anastrozole versus tamoxifen as initial adjuvant therapy for patients with early-stage estrogen receptor-positive breast cancer.
Hillner BE
Cancer; 2004 Sep; 101(6):1311-22. PubMed ID: 15368322
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
